Drugs / CO2
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT00688441 | Jul → Oct 2008 | seasonal allergic rhinitis | Capnia, Inc. | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| — | NCT05798416 Comparator | Feb → Apr 2023 | acute mountain sickness | State Key Laboratory of Respiratory Disease | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CO2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00688441 ↗ |
| Known as | carbon dioxide | “nasal, non-inhaled administration of carbon dioxide (CO2) in patients with seasonal allergic rhinitis” NCT00688441 ↗ |
| Route | Intranasal | “nasal, non-inhaled administration” NCT00688441 ↗ |